Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) Return on equity
Medtronic PLC's return on equity over the twelve months to 31 July 2026 was 10.6%, up 0.8 percentage points from fiscal 2026 (9.77%). Over the past ten years it has ranged from 6.14% (fiscal 2018) to 9.77% (fiscal 2026) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −15.3% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 9.77% | 0.32 |
| FY2025 | 9.45% | 2.25 |
| FY2024 | 7.20% | 0.00 |
| FY2023 | 7.20% | (2.46) |
| FY2022 | 9.66% | 2.62 |
| FY2021 | 7.04% | (2.44) |
| FY2020 | 9.48% | 0.31 |
| FY2019 | 9.17% | 3.03 |
| FY2018 | 6.14% | (1.73) |
| FY2017 | 7.87% | 1.15 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 38.5% |
| GEHC GE HealthCare Technologies Inc. compare | 19.2% |
| SYK Stryker Corporation compare | 16.5% |
| BSX Boston Scientific Corporation compare | 15.4% |
| STE STERIS plc compare | 11.4% |
| ABT Abbott Laboratories compare | 10.6% |
| MDT Medtronic PLC | 10.6% |
| PHG Koninklijke Philips N.V. compare | 10.2% |
| EW Edwards Lifesciences Corporation compare | 9.42% |
| Medical Devices industry median | −15.3% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement